Once believed to be a condition that children outgrow, attention deficit hyperactivity disorder (ADHD) is now recognized as a ...

Centanafadine XR demonstrated efficacy in improving symptoms in adults with attention-deficit/hyperactivity disorder and comorbid anxiety.

The Great ADHD Myth? Is a 1x60, produced by Minnow Films. The Commissioning Editor for Channel 4 is Tim Hancock. The ...

The FDA has approved Otsuka Pharmaceutical’s once-daily extended-release capsule Simtriyo (centanafadine) f | Approval of the ...

Caring for patients with ADHD, or those who potentially have ADHD, extends far beyond diagnosis and prescribing.

The Food and Drug Administration (FDA) approved a new "first-in-class" medication to help manage attention deficit ...

For decades, ADHD was viewed as a childhood condition that mostly affected boys. Researchers now know ADHD manifests ...

Ann Childress, M.D., lead investigator for the Phase 3 trial, stated, “The study demonstrated clinically meaningful improvements in ADHD symptoms while maintaining a favorable safety profile, and the ...

A new documentary will investigate the causes of ADHD and consider whether treating young brains with medication is the best approach.

Dexamphetamine and methylphenidate were equally effective in treating the core features of ADHD in children, but participants ...

News and commentary from the psychiatry world ...

Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and ...